TCE
-
【Product for Licensing】T-cell engager (TCE), bispecific, trispecific, and multispecific products are available
If you are interested in similar assets, please contact DrugTimes BD Team at BD@drugtimes.cn asap. Many thanks!~
-
GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
Congratulations to Chimagen and GSK!
-
The biggest biotech financing of the year has been born! Who will be the next “buyer”?
What will be the fate of this new player in autoimmune diseases in the future?
